Should CD4 Levels be Monitored in a Patient on Temozolomide?
Introduction: Temozolomide is an alkylating agent, indicated in the treatment of refractory anaplastic astrocytoma and newly diagnosed glioblastoma. We describe a case of Salmonella typhimurium bacteraemia associated with septic arthritis in the setting of concurrent temozolomide use. Case: A 67-ye...
| Published in: | European Journal of Case Reports in Internal Medicine |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
SMC MEDIA SRL
2021-03-01
|
| Subjects: | |
| Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/2276 |